FK506E (modified release tacrolimus) + Prograf (tacrolimus)
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Liver Transplantation
Conditions
Liver Transplantation
Trial Timeline
Apr 1, 2009 → Mar 1, 2010
NCT ID
NCT00909571About FK506E (modified release tacrolimus) + Prograf (tacrolimus)
FK506E (modified release tacrolimus) + Prograf (tacrolimus) is a phase 3 stage product being developed by Astellas Pharma for Liver Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT00909571. Target conditions include Liver Transplantation.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00909571 | Phase 3 | Completed |
Competing Products
20 competing products in Liver Transplantation